Ashline David J, Duk Maria, Lukasiewicz Jolanta, Reinhold Vernon N, Lisowska Elwira, Jaskiewicz Ewa
The Glycomics Center, University of New Hampshire, Durham, NH 03824, USA.
Polish Academy of Sciences, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland.
Glycobiology. 2015 May;25(5):570-81. doi: 10.1093/glycob/cwu188. Epub 2014 Dec 30.
Glycophorins C and D are highly glycosylated integral sialoglycoproteins of human red blood cell membranes carrying the Gerbich blood group antigens. The O- and N-glycosidic chains of the major erythrocyte glycoprotein (Lisowska E. 2001, Antigenic properties of human glycophorins - an update. Adv Exp Med Biol, 491:155-169; Tomita M and Marchesi VT. 1975, Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci USA, 72:2964-2968.) are well characterized but the structure of GPC N-glycans has remained unknown. This problem became important since it was reported that GPC N-glycans play an essential role in the interaction with Plasmodium falciparum EBA-140 merozoite ligand. The elucidation of these structures seems essential for full characterization of the GPC binding site for the EBA-140 ligand. We have employed detailed structural analysis using sequential mass spectrometry to show that many GPC N-glycans contain H2 antigen structures and several contain polylactosamine structures capped with fucose. The results obtained indicate structural heterogeneity of the GPC N-glycans and show the existence of structural elements not found in glycophorin A N-glycans. Our results also open a possibility of new interpretation of the data concerning the binding of P. falciparum EBA-140 ligand to GPC. We hypothesize that preferable terminal fucosylation of N-glycosidic chains containing repeating lactosamine units of the GPC Gerbich variant could be an explanation for why the EBA-140 ligand does not react with GPC Gerbich and an indication that the EBA-140 interaction with GPC is distinctly dependent on the GPC N-glycan structure.
血型糖蛋白C和D是人类红细胞膜上高度糖基化的整合唾液酸糖蛋白,携带杰尔比希血型抗原。主要红细胞糖蛋白的O-和N-糖苷链(利索夫斯卡E. 2001,人类血型糖蛋白的抗原特性——最新进展。《实验医学与生物学进展》,491:155 - 169;富田M和马尔凯西VT. 1975,人类红细胞血型糖蛋白的氨基酸序列和寡糖连接位点。《美国国家科学院院刊》,72:2964 - 2968。)已得到充分表征,但血型糖蛋白C的N-聚糖结构仍不清楚。自从有报道称血型糖蛋白C的N-聚糖在与恶性疟原虫EBA - 140裂殖子配体的相互作用中起重要作用后,这个问题就变得很重要了。阐明这些结构似乎对于全面表征EBA - 140配体的血型糖蛋白C结合位点至关重要。我们采用了串联质谱的详细结构分析来表明,许多血型糖蛋白C的N-聚糖含有H2抗原结构,还有一些含有被岩藻糖封端的多聚乳糖胺结构。所获得的结果表明血型糖蛋白C的N-聚糖存在结构异质性,并显示出血型糖蛋白A的N-聚糖中未发现的结构元件的存在。我们的结果也为关于恶性疟原虫EBA - 140配体与血型糖蛋白C结合的数据提供了新的解释可能性。我们推测,血型糖蛋白C杰尔比希变体中含有重复乳糖胺单元的N-糖苷链的优先末端岩藻糖基化可能是EBA - 140配体不与血型糖蛋白C杰尔比希反应的原因,也表明EBA - 140与血型糖蛋白C的相互作用明显依赖于血型糖蛋白C的N-聚糖结构。